Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Simó JM[au]:

Search results

Items: 39

1.

Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation.

Fort-Gallifa I, Hernández-Aguilera A, García-Heredia A, Cabré N, Luciano-Mateo F, Simó JM, Martín-Paredero V, Camps J, Joven J.

Int J Mol Sci. 2017 May 4;18(5). pii: E973. doi: 10.3390/ijms18050973.

2.

Biochemical indices of oxidative stress and inflammation in the evaluation of peripheral artery disease.

Fort-Gallifa I, García-Heredia A, Hernández-Aguilera A, Simó JM, Sepúlveda J, Martín-Paredero V, Camps J, Joven J.

Free Radic Biol Med. 2016 Aug;97:568-576. doi: 10.1016/j.freeradbiomed.2016.07.011. Epub 2016 Jul 19.

PMID:
27449545
3.

Erratum to: Preliminary study on serum paraoxonase-1 status and chemokine (C-C motif) ligand 2 in hospitalized elderly patients with catheter-associated asymptomatic bacteriuria.

Iftimie S, García-Heredia A, Pujol I, Ballester F, Fort-Gallifa I, Simó JM, Joven J, Camps J, Castro A.

Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1425. No abstract available.

PMID:
27435069
4.

Preliminary study on serum paraoxonase-1 status and chemokine (C-C motif) ligand 2 in hospitalized elderly patients with catheter-associated asymptomatic bacteriuria.

Iftimie S, García-Heredia A, Pujol I, Ballester F, Fort-Gallifa I, Simó JM, Joven J, Camps J, Castro A.

Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1417-24. doi: 10.1007/s10096-016-2679-8. Epub 2016 Jun 22. Erratum in: Eur J Clin Microbiol Infect Dis. 2016 Sep;35(9):1425.

PMID:
27334497
5.

A preliminary study of paraoxonase-1 in infected patients with an indwelling central venous catheter.

Iftimie S, García-Heredia A, Pujol I, Ballester F, Fort-Gallifa I, Simó JM, Joven J, Castro A, Camps J.

Clin Biochem. 2016 Apr;49(6):449-457. doi: 10.1016/j.clinbiochem.2015.11.006. Epub 2015 Nov 11.

PMID:
26562028
6.

[Psychological alterations in patients with adult celiac disease].

Martínez Cerezo FJ, Castillejo G, Guillen N, Morente V, Simó JM, Tena FJ, Marsal J, Pascual D.

Gastroenterol Hepatol. 2014 Apr;37(4):240-5. doi: 10.1016/j.gastrohep.2013.12.006. Epub 2014 Feb 25. Spanish.

PMID:
24576676
7.

[Response to «Spectrum of gluten-sensitive entheropathy in patients with dismotility-like dyspepsia»].

Martínez Cerezo FJ, Castillejo G, Morente V, Guillen N, Simó JM, Tena FJ, Urdin B, Marsal J, Pascual D.

Gastroenterol Hepatol. 2014 Jan;37(1):48-9. doi: 10.1016/j.gastrohep.2013.02.009. Epub 2013 Dec 14. Spanish. No abstract available.

PMID:
24333138
8.

First human isolate of Mycobacterium madagascariense in the sputum of a patient with tracheobronchitis.

Ballester F, Alcaide F, Pujol I, Hernández-Flix S, Simó JM, Joven J, Camps J.

Clin Chem Lab Med. 2013 Feb;51(2):e35-6. No abstract available.

9.

Identification of recent HIV-1 infection among newly diagnosed cases in Catalonia, Spain (2006-08).

Romero A, González V, Esteve A, Martró E, Matas L, Tural C, Pumarola T, Casanova A, Ferrer E, Caballero E, Ribera E, Margall N, Domingo P, Farré J, Puig T, Sauca MG, Barrufet P, Amengual MJ, Navarro G, Navarro M, Vilaró J, Ortín X, Ortí A, Pujol F, Prat JM, Massabeu A, Simó JM, Villaverde CA, Benítez MÁ, Garcia I, Díaz O, Becerra J, Ros R, Sala R, Rodrigo I, Miró JM, Casabona J; AERI Study group.

Eur J Public Health. 2012 Dec;22(6):802-8. doi: 10.1093/eurpub/ckr179. Epub 2011 Dec 8.

PMID:
22158995
10.

First human isolate of Mycobacterium poriferae in the sputum of a patient with chronic bronchitis.

Ballester F, Pujol I, Alcaide F, Pizarro I, Simó JM, Joven J, Camps J.

J Clin Microbiol. 2011 Aug;49(8):3107-8. doi: 10.1128/JCM.00436-11. Epub 2011 Jun 8. No abstract available.

11.

Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.

Romero A, Sued O, Puig T, Esteve A, Pumarola T, Casabona J, González V, Matas L, Tural C, Rodrigo I, Margall N, Domingo P, Casanova A, Ferrer E, Caballero E, Ribera E, Farré J, Puig T, Amengual MJ, Navarro G, Prat JM, Masabeu A, Simó JM, Villaverde CA, Barrufet P, Sauca MG, Ortin X, Ortí A, Navarro R, Euras JM, Vilaró J, Villà MC, Montull S, Vilanova C, Pujol F, Díaz O, Miró JM; AERI study Group.

Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):482-9. doi: 10.1016/j.eimc.2011.03.001. Epub 2011 May 2.

PMID:
21543135
12.

Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based study.

Aragonès G, Guardiola M, Barreda M, Marsillach J, Beltrán-Debón R, Rull A, Mackness B, Mackness M, Joven J, Simó JM, Camps J.

J Lipid Res. 2011 May;52(5):1055-61. doi: 10.1194/jlr.D014134. Epub 2011 Feb 17.

13.

Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria.

Camps J, Pujol I, Ballester F, Joven J, Simó JM.

Antimicrob Agents Chemother. 2011 Apr;55(4):1325-31. doi: 10.1128/AAC.01502-10. Epub 2011 Jan 3. Review.

14.

Trigonosins A-F, daphnane diterpenoids from Trigonostemon thyrsoideum.

Li SF, Di YT, Li SL, Zhang Y, Yang FM, Sun QY, Simo JM, He HP, Hao XJ.

J Nat Prod. 2011 Mar 25;74(3):464-9. doi: 10.1021/np1006444. Epub 2010 Dec 30.

PMID:
21192108
15.

Oral biopsy in dental practice.

Mota-Ramírez A, Silvestre FJ, Simó JM.

Med Oral Patol Oral Cir Bucal. 2007 Nov 1;12(7):E504-10. Review.

16.

Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.

Vilella E, Virgos C, Murphy M, Martorell L, Valero J, Simó JM, Joven J, Fernández-Ballart J, Labad A.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Sep;29(7):1169-74.

PMID:
16076517
17.

Differences between genotyping and phenotyping methods for assessing apolipoprotein(a) size polymorphisms.

Simó JM, Camps J, Martín S, Pedro-Botet J, Ferré N, Gómez F, Joven J.

Clin Chem Lab Med. 2003 Oct;41(10):1340-4.

PMID:
14580163
19.
20.

Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.

Martín S, Pedro-Botet J, Joven J, Simó JM, Ladona MG, Pavesi M, Rubiés-Prat J.

J Lab Clin Med. 2002 Mar;139(3):181-7.

PMID:
11944029
21.

Plasma homocysteine concentrations in patients with liver cirrhosis.

Ferré N, Gómez F, Camps J, Simó JM, Murphy MM, Fernández-Ballart J, Joven J.

Clin Chem. 2002 Jan;48(1):183-5. No abstract available.

22.
23.

Polymorphisms in human apolipoprotein(a) kringle IV-10 and coronary artery disease: relationship to allele size, plasma lipoprotein(a) concentration, and lysine binding site activity.

Simó JM, Joven J, Vilella E, Ribas M, Figuera L, Virgos C, Sundaram IM, Hoover-Plow J.

J Mol Med (Berl). 2001 Jun;79(5-6):294-9.

PMID:
11485023
24.

Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.

Simó JM, Joven J, Vilella E, Ribas M, Pujana MA, Sundaram IM, Hammel JP, Hoover-Plow JL.

Thromb Haemost. 2001 Mar;85(3):412-7.

PMID:
11307806
25.

Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction.

Virgos C, Joven J, Simó JM, Vilella E, Camps J, Arcelus R, Blanco-Vaca F, Figuera L, Martorell L.

Clin Biochem. 2000 Aug;33(6):509-12. No abstract available.

PMID:
11074245
26.
27.

Evaluation of a particle-enhanced turbidimetric immunoassay for the measurement of ferritin: application to patients participating in an autologous blood transfusion program.

Gómez F, Simó JM, Camps J, Clivillé X, Bertran N, Ferré N, Bofill C, Joven J.

Clin Biochem. 2000 Apr;33(3):191-6.

PMID:
10913517
28.
29.

Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia.

Virgos C, Martorell L, Simó JM, Valero J, Figuera L, Joven J, Labad A, Vilella E.

Neuroreport. 1999 Jul 13;10(10):2035-8.

PMID:
10424670
30.

Altered composition of lipoproteins in liver cirrhosis compromises three homogeneous methods for HDL-cholesterol.

Camps J, Simó JM, Guaita S, Ferré N, Joven J.

Clin Chem. 1999 May;45(5):685-8. No abstract available.

31.

Lipoprotein(a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction.

Joven J, Simó JM, Vilella E, Camps J, Masana L, de Febrer G, Camprubí M, Richart C, Bardaji A, Casao E, Pocovi M, Civeira F.

Atherosclerosis. 1998 Sep;140(1):155-9.

PMID:
9733226
32.
33.

The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia.

Joven J, Espinel E, Simó JM, Vilella E, Camps J, Oliver A.

Atherosclerosis. 1996 Oct 25;126(2):243-52.

PMID:
8902150
34.

Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery.

Sans T, Bofil C, Joven J, Clivillé X, Simó JM, Llobet X, Peró A, Galbany J.

Transfusion. 1996 Sep;36(9):822-6.

PMID:
8823459
35.

Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.

Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C.

Clin Chem. 1995 Jun;41(6 Pt 1):908-13.

36.

Semiautomated determination of glycated albumin in glycaemic control of diabetic patients.

Cabre M, Joven J, Simo JM, Matas C, Camps J.

Clin Biochem. 1994 Aug;27(4):307-9. No abstract available.

PMID:
8001294
37.

Automated latex agglutination immunoassay of serum ferritin with a centrifugal analyzer.

Simó JM, Joven J, Clivillé X, Sans T.

Clin Chem. 1994 Apr;40(4):625-9.

38.
39.

Toxicity of lovastatin in rats with experimentally induced nephrotic syndrome.

Joven J, Vilella E, Camps J, Masana L, Turner PR, Simó JM, Villabona C.

Nephron. 1990;56(4):399-404.

PMID:
2079999

Supplemental Content

Support Center